| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
79,968 |
72,839 |
$7.36M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
98,367 |
88,382 |
$6.68M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14,714 |
14,154 |
$1.63M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
15,490 |
14,372 |
$1.57M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,570 |
7,367 |
$837K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
14,713 |
4,819 |
$540K |
| 99477 |
|
1,676 |
1,430 |
$522K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,433 |
3,356 |
$409K |
| 99220 |
|
4,346 |
3,886 |
$379K |
| 99233 |
Prolong inpt eval add15 m |
6,454 |
2,562 |
$341K |
| 99223 |
Prolong inpt eval add15 m |
3,332 |
2,950 |
$290K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
5,512 |
4,898 |
$258K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,221 |
2,059 |
$250K |
| 90670 |
|
9,225 |
8,882 |
$209K |
| 99215 |
Prolong outpt/office vis |
2,669 |
2,468 |
$191K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
2,009 |
1,845 |
$180K |
| 90686 |
|
8,449 |
8,186 |
$178K |
| 90680 |
|
7,419 |
7,088 |
$161K |
| 99381 |
|
1,262 |
1,162 |
$134K |
| 93000 |
|
4,982 |
4,744 |
$132K |
| 90698 |
|
5,869 |
5,673 |
$128K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
3,339 |
2,614 |
$123K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
892 |
850 |
$109K |
| 99385 |
|
848 |
805 |
$108K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
4,055 |
3,303 |
$108K |
| 90697 |
|
4,957 |
4,625 |
$108K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,582 |
2,357 |
$102K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
4,038 |
3,692 |
$99K |
| 90633 |
|
4,410 |
4,278 |
$97K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,231 |
1,040 |
$90K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,914 |
8,377 |
$88K |
| 90710 |
|
3,618 |
3,488 |
$80K |
| 90677 |
|
2,701 |
2,509 |
$65K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,916 |
1,515 |
$64K |
| 36415 |
Collection of venous blood by venipuncture |
15,249 |
14,353 |
$59K |
| 90744 |
|
2,676 |
2,588 |
$58K |
| 99226 |
|
1,069 |
632 |
$57K |
| 99217 |
|
1,900 |
1,686 |
$56K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
631 |
535 |
$55K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
456 |
399 |
$52K |
| G0008 |
Administration of influenza virus vaccine |
2,910 |
2,860 |
$46K |
| D1206 |
Topical application of fluoride varnish |
1,422 |
1,391 |
$35K |
| 90682 |
|
1,029 |
994 |
$34K |
| 96127 |
|
4,946 |
4,534 |
$29K |
| 3074F |
|
45,250 |
41,149 |
$28K |
| 99460 |
|
302 |
269 |
$26K |
| 99225 |
|
954 |
578 |
$24K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
814 |
806 |
$24K |
| 99464 |
|
408 |
331 |
$24K |
| 92551 |
|
2,250 |
2,173 |
$23K |
| 99462 |
|
572 |
462 |
$23K |
| 82962 |
|
1,301 |
1,226 |
$21K |
| 90674 |
|
675 |
656 |
$16K |
| 90662 |
|
1,331 |
1,313 |
$15K |
| 90651 |
|
650 |
619 |
$15K |
| 99219 |
|
322 |
284 |
$13K |
| 3044F |
|
9,062 |
8,119 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
217 |
212 |
$11K |
| 90696 |
|
452 |
431 |
$10K |
| 99221 |
|
100 |
44 |
$10K |
| 90661 |
|
496 |
485 |
$9K |
| 99386 |
|
59 |
54 |
$9K |
| 0072A |
|
225 |
221 |
$9K |
| 99205 |
Prolong outpt/office vis |
47 |
36 |
$9K |
| 0071A |
|
202 |
187 |
$8K |
| 90700 |
|
294 |
287 |
$7K |
| 0001A |
|
174 |
171 |
$7K |
| G0009 |
Administration of pneumococcal vaccine |
275 |
270 |
$6K |
| 99442 |
|
298 |
272 |
$6K |
| 0002A |
|
157 |
153 |
$6K |
| 99173 |
|
2,267 |
2,191 |
$6K |
| 90480 |
|
138 |
133 |
$6K |
| 90734 |
|
258 |
248 |
$5K |
| 90648 |
|
177 |
176 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
211 |
193 |
$4K |
| 0124A |
|
108 |
104 |
$4K |
| 90715 |
|
125 |
121 |
$3K |
| 99236 |
Prolong inpt eval add15 m |
15 |
13 |
$3K |
| 0004A |
|
60 |
60 |
$2K |
| 96161 |
|
893 |
736 |
$2K |
| 90619 |
|
81 |
81 |
$2K |
| 3075F |
|
1,945 |
1,807 |
$2K |
| 99495 |
|
40 |
40 |
$2K |
| 99443 |
|
64 |
62 |
$2K |
| 99383 |
|
12 |
12 |
$2K |
| 91318 |
|
26 |
24 |
$2K |
| 0012A |
|
30 |
30 |
$1K |
| 91319 |
|
13 |
13 |
$1K |
| 0011A |
|
27 |
27 |
$1K |
| 90688 |
|
54 |
53 |
$974.34 |
| 99406 |
|
80 |
67 |
$969.74 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
69 |
61 |
$962.82 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
64 |
61 |
$946.94 |
| 90381 |
|
16 |
13 |
$895.25 |
| 90707 |
|
30 |
29 |
$651.84 |
| 90716 |
|
30 |
29 |
$651.84 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
481 |
409 |
$607.50 |
| 90621 |
|
14 |
13 |
$578.88 |
| W7000 |
|
99 |
96 |
$539.86 |
| 0081A |
|
17 |
13 |
$486.20 |
| 80305 |
|
98 |
82 |
$424.83 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
40 |
37 |
$413.41 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
23 |
12 |
$381.38 |
| 90685 |
|
19 |
19 |
$349.20 |
| 90694 |
|
294 |
288 |
$320.69 |
| 99306 |
Prolong nursin fac eval 15m |
14 |
13 |
$320.49 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$178.96 |
| 90732 |
|
45 |
44 |
$146.54 |
| 90653 |
|
68 |
68 |
$120.22 |
| 36416 |
|
596 |
484 |
$110.80 |
| 91308 |
|
170 |
159 |
$0.02 |
| 91312 |
|
80 |
80 |
$0.01 |
| 3078F |
|
37,617 |
34,225 |
$0.00 |
| 91300 |
|
109 |
108 |
$0.00 |
| 3079F |
|
9,459 |
8,719 |
$0.00 |
| 91307 |
|
79 |
78 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
25 |
24 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14 |
12 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
12 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
13 |
$0.00 |